Strategic Investment The recent strategic investment from Cadwell Industries signals a potential channel for U.S. market access, co development, and distribution for Seer Medical's home based epilepsy diagnostics. This partnership could accelerate go to market with neurodiagnostic expertise, align on clinical validation, and open hospital networks as potential customers.

US Market Entry Seer Medical has established a U.S. presence with a Rochester office and plans to hire, indicating readiness to pursue enterprise deals with U.S. health systems, ambulatory networks, and payer programs seeking remote monitoring to reduce in clinic visits and expedite epilepsy management.

Growth Capabilities Ongoing headcount growth and Melbourne HQ expansion demonstrate scaling capabilities in manufacturing, industrial design, data science, and software development, enabling larger pilots, robust post sale support, and faster deployment across regions.

Global Growth Awards for international trade and startup excellence, plus expansions in Victoria and Oceania, position Seer as a growth partner for hospitals and government funded programs. Explore opportunities tied to funding initiatives to subsidize pilots and scale adoption.

Platform Readiness Seer Medical's tech stack and focus on long term remote monitoring suggest a platform ready solution with potential for EMR EHR integration, secure data handling, and analytics driven patient engagement. Target IT leaders in health systems for interoperability led pilots and cross sell to related neuro and sleep diagnostics.